Tianjin Medical University Second Hospital

This study tests a drug called tunlametinib in 15 adults with advanced solid tumors that have a specific change in the NRAS gene and have not responded to other treatments. The goal is to see if the drug can shrink tumors or slow their growth. Participants will take the drug by m…

This study looks at whether a urine test that detects tumor DNA and RNA can guide the need for a second surgery in people with high-risk non-muscle-invasive bladder cancer. About 60 participants will provide urine samples before a planned second surgery, and the test results will…